Summary Apixaban is an oral ... regimen in clinical trials without the need for anticoagulation monitoring or dosage adjustment. Apixaban has multiple elimination pathways, and its ...
Novel anticoagulants include dabigatran, rivaroxaban and apixaban. Based on the RE-LY study, a 150-mg dose of dabigatran as compared with warfarin was shown to reduce the rate of stroke ...
A recent study from National Taiwan University Hospital shows that apixaban, a blood-thinning medication, can help prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results